Regulation 35 Amendment to paragraph 11
In paragraph 11 (time limits for marketing authorisations – pharmacologically equivalent products)—
in sub-paragraph (1) for “pharmacologically equivalent” substitute “generic veterinary medicinal”;
for sub-paragraph (3) substitute—
“(3)The product may not be placed on the market until the end of the longest of the following periods which is relevant—
(a)subject to sub-paragraph (3A), 10 years in the case of a veterinary medicinal product authorised for major species;
(b)18 years in the case of a veterinary medicinal product authorised for bees; and
(c)14 years for a veterinary medicinal product authorised for all other species.
(3A)Where the product—
(a)is intended for administration to a major species; and
(b)contains an active substance which is an antimicrobial which has not been an active substance in a veterinary medicinal product previously subject to a marketing authorisation in Great Britain,
the period mentioned in sub-paragraph (3)(a) is 14 years.
(3B)Where a patent in relation to a reference product has lapsed, the summary of product characteristics of the relevant generic product must be updated in order to include the protected information.
(3C)Where, as a result of a variation to an existing marketing authorisation a product is accorded a new marketing authorisation number any relevant protection period applies in relation to that product.
(3D)In this regulation “major species” means cattle, sheep (for meat production), pigs, chickens, dogs and cats.”;
in the heading for “pharmacologically equivalent” substitute “generic veterinary medicinal”.